Detalhe da pesquisa
1.
25-Hydroxyvitamin D Serum Levels Linked to Single Nucleotide Polymorphisms (SNPs) (rs2228570, rs2282679, rs10741657) in Skeletal Muscle Aging in Institutionalized Elderly Men Not Supplemented with Vitamin D.
Int J Mol Sci
; 23(19)2022 Oct 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36233147
2.
Co-occurrence of cohesin complex and Ras signaling mutations during progression from myelodysplastic syndromes to secondary acute myeloid leukemia.
Haematologica
; 106(8): 2215-2223, 2021 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32675227
3.
Clinical, biological, and prognostic implications of SF3B1 co-occurrence mutations in very low/low- and intermediate-risk MDS patients.
Ann Hematol
; 100(8): 1995-2004, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-33409621
4.
Genome-wide transcriptomics leads to the identification of deregulated genes after deferasirox therapy in low-risk MDS patients.
Pharmacogenomics J
; 20(5): 664-671, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32015457
5.
Redefining synchronous colorectal cancers based on tumor clonality.
Int J Cancer
; 144(7): 1596-1608, 2019 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30151896
6.
Chronic graft-versus-host disease could ameliorate the impact of adverse somatic mutations in patients with myelodysplastic syndromes and hematopoietic stem cell transplantation.
Ann Hematol
; 98(9): 2151-2162, 2019 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-31312927
7.
Transcriptomic rationale for synthetic lethality-targeting ERCC1 and CDKN1A in chronic myelomonocytic leukaemia.
Br J Haematol
; 182(3): 373-383, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29797327
8.
The presence of genomic imbalances is associated with poor outcome in patients with burkitt lymphoma treated with dose-intensive chemotherapy including rituximab.
Br J Haematol
; 172(3): 428-38, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26567765
9.
Single nucleotide polymorphism array karyotyping: a diagnostic and prognostic tool in myelodysplastic syndromes with unsuccessful conventional cytogenetic testing.
Genes Chromosomes Cancer
; 52(12): 1167-77, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24123380
10.
Response to lenalidomide in myelodysplastic syndromes with del(5q): influence of cytogenetics and mutations.
Br J Haematol
; 162(1): 74-86, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23614682
11.
Imatinib therapy of chronic myeloid leukemia restores the expression levels of key genes for DNA damage and cell-cycle progression.
Pharmacogenet Genomics
; 22(5): 381-8, 2012 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-22388797
12.
Integration of global spectral karyotyping, CGH arrays, and expression arrays reveals important genes in the pathogenesis of glioblastoma multiforme.
Ann Surg Oncol
; 19(7): 2367-79, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22395973
13.
Expression of VAV1 in the tumour microenvironment of glioblastoma multiforme.
J Neurooncol
; 110(1): 69-77, 2012 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-22864683
14.
Down-regulation of EVI1 is associated with epigenetic alterations and good prognosis in patients with acute myeloid leukemia.
Haematologica
; 96(10): 1448-56, 2011 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21750091
15.
Correlation of myelodysplastic syndromes with i(17)(q10) and TP53 and SETBP1 mutations.
Br J Haematol
; 171(1): 137-41, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25716545
16.
Comprehensive Custom NGS Panel Validation for the Improvement of the Stratification of B-Acute Lymphoblastic Leukemia Patients.
J Pers Med
; 10(3)2020 Sep 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-32967112
17.
Effects of imatinib mesylate on normal bone marrow cells from chronic myeloid leukemia patients in complete cytogenetic response.
Leuk Res
; 33(1): 170-3, 2009 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-18722011
18.
An international standardization programme towards the application of gene expression profiling in routine leukaemia diagnostics: the Microarray Innovations in LEukemia study prephase.
Br J Haematol
; 142(5): 802-7, 2008 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-18573112
19.
Fluorescence in situ hybridization improves the detection of 5q31 deletion in myelodysplastic syndromes without cytogenetic evidence of 5q-.
Haematologica
; 93(7): 1001-8, 2008 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-18591625
20.
Prospective randomized trial of 5 days azacitidine versus supportive care in patients with lower-risk myelodysplastic syndromes without 5q deletion and transfusion-dependent anemia.
Leuk Lymphoma
; 59(5): 1095-1104, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28836866